Related Experiment Video
Updated: Jan 3, 2026
09:44
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
Published on: July 7, 2023
4.8K
Biomaterial-assisted scalable cell production for cell therapy
Ruoyu Chen1, Ling Li1, Lu Feng1
1Key Laboratory for Advanced Materials Processing Technology of Ministry of Education, Biomanufacturing and Rapid Forming Technology Key Laboratory of Beijing, Department of Mechanical Engineering, Tsinghua University, Beijing, 100084, China.
Biomaterials
|November 27, 2019
Summary
Biomaterials enhance cell therapy production by creating ideal microenvironments for cell growth. This review covers biomaterial-assisted methods to improve quality and efficiency in cell manufacturing for treating diseases.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Cell Therapy Manufacturing
Background:
- Cell therapy is a promising treatment for refractory diseases.
- The cell therapy market is expanding, driving demand for automated, high-quality cell production.
- Current methods face challenges in scaling up production while maintaining cell quality.
Purpose of the Study:
- To review recent advancements in biomaterial-assisted cell production.
- To explore emerging techniques for enhancing therapeutic cell manufacturing.
- To highlight the role of biomaterials in improving cell therapy quality and efficiency.
Main Methods:
- Review of scientific literature on biomaterial applications in cell production.
- Analysis of emerging techniques in automated cell manufacturing.
- Discussion of quality control and Good Manufacturing Practice (GMP) considerations.
Main Results:
- Biomaterials create biomimetic microenvironments supporting cell adhesion and proliferation.
- Biomaterial-assisted methods maintain target cell genotype and phenotype during production.
- Integration of biomaterials with automation offers improved quality control and efficiency.
Conclusions:
- Biomaterial-assisted cell production is crucial for meeting the growing demand for cell therapies.
- Automation and biomaterials can standardize GMP-compliant cell manufacturing processes.
- These approaches promise to enhance the clinical accessibility and efficacy of cell-based treatments.
